id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0507-0002,FDA,FDA-2009-N-0507,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format",Notice,N-Notice,2010-05-04T04:00:00Z,2010,5,2010-05-04T04:00:00Z,2010-06-04T03:59:59Z,2024-11-07T22:18:17Z,2010-10361,1,0,0900006480ae603f
FDA-2009-N-0507-0001,FDA,FDA-2009-N-0507,Agency Information Collection Activities: Proposed Collection; Comment Request; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format,Notice,N-Notice,2009-11-06T05:00:00Z,2009,11,2009-11-06T05:00:00Z,2010-01-06T04:59:59Z,2009-11-06T17:11:19Z,E9-26760,0,0,0900006480a517ab